mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |